[Skip to Content]
[Skip to Content Landing]
Article
December 20, 1976

Evaluation of a New Aerosolized Steroid for Asthma Therapy: Beclomethasone Dipropionate (Vanceril Inhaler)

Author Affiliations

Dr Ballin is Director, AMA Department of Drugs. This communication was prepared with the assistance of consultants.

JAMA. 1976;236(25):2891-2893. doi:10.1001/jama.1976.03270260047033
Abstract

Beclomethasone dipropionate, an esterified derivative of betamethasone, can be given in small doses in aerosol form to patients with severe asthma whose symptoms cannot be controlled with nonsteroidal agents (bronchodilators and cromolyn). Many asthmatic patients who previously required systemic steroids can be transferred to this safer anti-inflammatory agent. In usual doses, beclomethasone produces few, if any, systemic side effects. The only substantial reaction is Candida infections of the oropharynx and larynx.

(JAMA 236:2891-2893, 1976)

×